Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04465864 · ClinicalTrials.gov registry record · Phase 4
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
A Phase 4 study of Cataract and Glaucoma, Primary Open Angle, sponsored by Wolstan and Goldberg Eye Associates.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04465864 is a Phase 4 study of Cataract and Glaucoma, Primary Open Angle that has completed, run by Wolstan and Goldberg Eye Associates. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04465864, a Phase 4 study of Cataract and Glaucoma, Primary Open Angle, has completed, sponsored by Wolstan and Goldberg Eye Associates.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized, controlled treatment with an intracanalicular dexamethasone (0.4mg) insert following cataract surgery with intraocular lens implant (IOL) combined with minimally invasive glaucoma surgery (MIGS), specifically iStent, iStent inject or KDB in patients with primary open angle glaucoma (POAG) or ocular hypertension (OHTN)
Conditions Studied
Interventions
- DRUG Intracanalicular Dexamethasone, 0.4 mg insert
Study Locations (1)
California
- Wolstan and Goldberg Eye Associates - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2021-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04465864
The ClinicalTrials.gov registry entry for NCT04465864 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The listed sponsor is Wolstan and Goldberg Eye Associates, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Intracanalicular Dexamethasone, 0.4 mg insert is the first listed.
NCT04465864 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04465864 about?
NCT04465864 is a clinical study titled "Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert". Randomized, controlled treatment with an intracanalicular dexamethasone (0.4mg) insert following cataract surgery with intraocular lens implant (IOL) combined with minimally invasive glaucoma surgery (MIGS), specifically iStent, iStent inject or KDB in patients with primary open angle glaucoma (POAG...
What is the current status of trial NCT04465864?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2020-02-10. Estimated completion is 2021-01-31.
What conditions does trial NCT04465864 study?
This clinical trial studies the following conditions: Cataract, Glaucoma, Primary Open Angle.
What interventions are being tested in trial NCT04465864?
The interventions under investigation include: Intracanalicular Dexamethasone, 0.4 mg insert (DRUG).
Who is sponsoring clinical trial NCT04465864?
This trial is sponsored by Wolstan and Goldberg Eye Associates, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04465864 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.